Inventor
Sharada Shenvi Labadie
Inventor
Sunnyvale, CA, US
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
A61KPreparations for medical, dental or toiletry purposes21%
C07CAcyclic or carbocyclic compounds2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C12NMicroorganisms or enzymes2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
10,966,963Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof202110,654,867Heteroaryl estrogen receptor modulators and uses thereof202010,053,451Heterocyclic estrogen receptor modulators and uses thereof201810,035,801Pyrazolo compounds and uses thereof201810,023,589Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators201810,022,354Pyrrolidine amide compounds as histone demethylase inhibitors20189,980,947Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof20189,969,732Tetrahydroisoquinoline estrogen receptor modulators and uses thereof20189,255,110'Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators'20168,461,328'Tricyclic heterocyclic compounds, compositions and methods of use thereof'20138,071,797'Heterocyclic antiviral compounds'20117,186,841'Antiinflammation agents'20077,176,314'Inflammation modulators'20077,157,580'Aminopyrimidine and aminopyridine anti-inflammation agents'20077,135,470'Thienopyridazines as IKK inhibitors'20067,105,666'Synthesis of purine derivatives'20066,979,693'Pyrazole derivatives-p38 MAP kinase inhibitors'20056,846,828'Aminopyrimidine and aminopyridine anti-inflammation agents'20056,846,834'Antiinflammation agents'20056,444,696'Pyrazole derivatives P38 MAP kinase inhibitors'20026,376,527'Pyrazole derivatives-p38 map kinase inhibitors'20026,316,466'Pyrazole derivatives P-38 MAP kinase inhibitors'20015,284,971'4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents'1994Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1994–2021Based in Sunnyvale, CA, US· patent location history
2001–2007Patents assigned to SYNTEX LLC (6)· patent assignee history
2005–2018Patents assigned to ROCHE PALO ALTO LLC (8)· patent assignee history
2005–2007Patents assigned to AMGEN INC (2)· patent assignee history
2013–2021Patents assigned to GENENTECH INC (8)· patent assignee history
2018Patents assigned to CONSTELLATION PHARMACEUTICALS INC (2)· patent assignee history
2018Based in South San Francisco, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENENTECH INC | 8 | 2013–2021 |
| ROCHE PALO ALTO LLC | 8 | 2005–2018 |
| SYNTEX LLC | 6 | 2001–2007 |
| AMGEN INC | 2 | 2005–2007 |
| CONSTELLATION PHARMACEUTICALS INC | 2 | 2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Sunnyvale, California, US | 21 | 1994–2021 |
| South San Francisco, California, US | 2 | 2018 |